CIGB-300
- Generic Name
- CIGB-300
Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application
Phase 2
Completed
- Conditions
- Squamous Cell Carcinoma of the CervixAdenocarcinoma of the Cervix
- Interventions
- First Posted Date
- 2012-07-13
- Last Posted Date
- 2016-08-02
- Lead Sponsor
- Laboratorio Elea Phoenix S.A.
- Target Recruit Count
- 18
- Registration Number
- NCT01639625
- Locations
- 🇦🇷
Instituto de Oncologia Angel H. Roffo, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Recurrent and Nonrecurrent Condyloma Treatment
Phase 2
Terminated
- Conditions
- Nonrecurrent CondylomaRecurrent Condyloma
- Interventions
- First Posted Date
- 2012-07-13
- Last Posted Date
- 2015-03-12
- Lead Sponsor
- Laboratorio Elea Phoenix S.A.
- Target Recruit Count
- 132
- Registration Number
- NCT01639638
- Locations
- 🇦🇷
Laboratorio Elea SACIFyA, Capital Federal, Buenos Aires, Argentina
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath